The Serum S100B Level as a Biomarker of Enteroglial Activation in Patients with Ulcerative Colitis

Table 2

Serum levels of GFAP and S100B in patients with ulcerative colitis and controls.

Variables	Patients; (𝑛=35)	Controls; (𝑛=40)	P
GFAP (ng/mL)	0 (100)	0 (100)	0.895
S100B (pg/mL)	4.54 (4.0–5.31)	12.5 (10.32–19.8)	<0.001

Values are expressed as 𝑛 (%) or median (25th–75th percentiles). GFAP indicates glial fibrillary acidic protein.